MENUNews Archive
Date: 04/30/2020
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Date: 04/30/2020
About a third of advanced prostate cancers don’t respond to drugs like enzalutamide. A multi-institutional clinical trial is shedding new light on these non-responsive tumors -- pointing toward unique molecular characteristics that might be targetable with new therapeutic approaches.
Date: 04/28/2020
With no national data source, a University of Michigan-led study has uncovered frequent spills, inconsistent PPE use and problems with closed-system transfer devices across 12 institutions.
Date: 04/28/2020
Drs. Arul Chinnaiyan and Janet Smith, both members of the Rogel Cancer Center, were among four University of Michigan professors elected to the National Academy of Sciences.
Date: 04/22/2020
Some types of gut bacteria are better than others at stimulating certain immune cells, specifically CD8+ T cells, in the body, they found.
Date: 04/22/2020
Using next-generation RNA sequencing techniques, a team of scientists from the University of Michigan Rogel Cancer Center has uncovered the gene signature of chromophobe renal cell carcinoma (ChRCC) and have extensively tested the expression of three new biomarkers.
Date: 04/17/2020
As health care organizations move to create policies and training to eliminate gender bias and harassment, medical ethicists argue that it’s not enough.
Date: 04/13/2020
Going through treatment for cancer can be scary on its own. Now, due to the COVID-19 pandemic, patients at the University of Michigan Rogel Cancer Center -- and cancer centers across the country -- are facing additional challenges.
Date: 04/05/2020
A new, collaborative study between the Rogel Cancer Center and researchers from the Columbia University Irving Medical Center and the Herbert Irving Comprehensive Cancer Center suggests a compound in development for a rare kidney stone disease may have potential against pancreatic cancer.
Date: 03/30/2020
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline health care workers.